2 results match your criteria: "University of Florence and Istituto Toscano Tumori (ITT)[Affiliation]"
Retraction Note: hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer.
Sci Rep
January 2025
Department of Experimental and Clinical Medicine, Section of Internal Medicine, University of Florence and Istituto Toscano Tumori (ITT), Florence, Italy.
hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer.
Sci Rep
November 2013
Department of Experimental and Clinical Medicine, Section of Internal Medicine, University of Florence and Istituto Toscano Tumori (ITT), Florence, Italy.
Angiogenesis is a potential target for cancer therapy. We identified a novel signaling pathway that sustains angiogenesis and progression in colorectal cancer (CRC). This pathway is triggered by β1 integrin-mediated adhesion and leads to VEGF-A secretion.
View Article and Find Full Text PDF